Arnold J. Levine - Jun 21, 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Director
Signature
/s/ Winston Kung, by power of attorney
Stock symbol
PMVP
Transactions as of
Jun 21, 2021
Transactions value $
-$116,362
Form type
4
Date filed
6/22/2021, 05:24 PM
Previous filing
Jun 14, 2021
Next filing
Aug 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Sale -$113K -3.39K -0.8% $33.22 420K Jun 21, 2021 Direct F1, F2
transaction PMVP Common Stock Sale -$3.78K -111 -0.03% $34.09 420K Jun 21, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.935 to $33.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.04 to $34.09, inclusive.